诚意药业(603811.SH)：帕拉米韦注射液获得药品注册证书

Group 1 - The company, Chengyi Pharmaceutical (603811.SH), has received approval from the National Medical Products Administration (NMPA) for the drug registration certificate of Palivizumab injection [1] - Palivizumab is indicated for the treatment of influenza A or B [1]